GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LENZ Therapeutics Inc (NAS:LENZ) » Definitions » Ending Cash Position

LENZ (LENZ Therapeutics) Ending Cash Position : $41.16 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is LENZ Therapeutics Ending Cash Position?

LENZ Therapeutics's Ending Cash Position for the quarter that ended in Sep. 2024 was $41.16 Mil.

LENZ Therapeutics's quarterly Ending Cash Position declined from Mar. 2024 ($200.47 Mil) to Jun. 2024 ($84.15 Mil) and declined from Jun. 2024 ($84.15 Mil) to Sep. 2024 ($41.16 Mil).

LENZ Therapeutics's annual Ending Cash Position increased from Dec. 2021 ($18.31 Mil) to Dec. 2022 ($44.44 Mil) but then declined from Dec. 2022 ($44.44 Mil) to Dec. 2023 ($35.14 Mil).


LENZ Therapeutics Ending Cash Position Historical Data

The historical data trend for LENZ Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LENZ Therapeutics Ending Cash Position Chart

LENZ Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Ending Cash Position
18.31 44.44 35.14

LENZ Therapeutics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.85 35.14 200.47 84.15 41.16

LENZ Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

LENZ Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=44.441+-9.301
=35.14

LENZ Therapeutics's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=84.149+-42.989
=41.16


LENZ Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of LENZ Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


LENZ Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
445 Marine View Avenue, STE No. 320, Del Mar, CA, USA, 92014
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.